J Genomics 2020; 8:7-10. doi:10.7150/jgen.40059
Short Research Paper
Draft genome sequences of Salmonella Oslo isolated from seafood and its laboratory generated auxotrophic mutant
1. Nitte University Center for Science Education and Research, Nitte (Deemed to be University), Deralakatte, Mangaluru - 575018, Karnataka, India.
2. University College Dublin, Food Safety and zoonoses, Dublin, Ireland.
Jazeela K, Chakraborty A, Rai P, Kumar BK, Srikumar S, van Nguyen S, Hurley D, Fanning S, Karunasagar I, Deekshit VK. Draft genome sequences of Salmonella Oslo isolated from seafood and its laboratory generated auxotrophic mutant. J Genomics 2020; 8:7-10. doi:10.7150/jgen.40059. Available from http://www.jgenomics.com/v08p0007.htm
In recent years, the concept of bacteria-mediated cancer therapy has gained significant attention as an alternative to conventional therapy. The focus has been on non-typhoidal Salmonella (NTS), particularly S. Typhimurium, for its anti-cancer properties, however, other NTS serovars such as Salmonella Oslo, which are associated with foodborne illnesses could potentially be effective anti-cancer agents. Here, we report the draft genome sequence of Salmonella Oslo isolated from seafood and its laboratory generated auxotrophic mutant.
Keywords: Non typhoidal Salmonella, Salmonella Oslo, Bacteria mediated cancer therapy, whole genome sequence
Non-typhoidal Salmonella (NTS) is one of the pathogens that frequently cause foodborne infections throughout the world. The pathogenic potential of NTS strains have been well understood . However, its therapeutic potential as an anti-cancer agent remain unexplored. Among more than 2500 NTS serovars, S. Typhimurium VNP20009 [2-4], an auxotrophic mutant strain of S. Typhimurium A1-R [5, 6], has been successfully studied and was even tested in phase I clinical trial for the treatment of solid tumors . Many features of Salmonella namely the ability to thrive in hypoxic environment of the tumor, to induce innate immune response against tumor or its bactofection, and ability to release anticancer genes within tumor were found to be favorable for tumor regression in animal models [8-10]. However, despite the success observed in animal models, the clinical trials didn't yield expected results. This prompted the researchers to look for alternative NTS strains for their anticancer properties. In this study, the aim was to sequence the genomes of Salmonella Oslo isolated from seafood and its laboratory generated auxotrophic mutant. The availability of genetic information provides a basis for further studies, particularly for investigating their role as anti-cancer agents.
Salmonella Oslo was isolated from seafood (squid sample) as per the protocol recommended by the FDA Bacteriological Analytical Manual  with minor modifications. Briefly, the seafood sample was pre-enriched in lactose broth, followed by enrichment in selenite cysteine broth and tetrathionate broth. Post enrichment, the sample was streaked on Hektoen enteric agar (HiMedia Laboratory Pvt Ltd, India). During the enrichment and plating steps, the incubation temperature was maintained at 37º C for 16 to 18 h. Colonies with specific morphological features were selected and were subjected to a series of biochemical tests such as indole test, methyl red test, Voges-Proskuer test, citrate test, triple sugar iron agar (TSIA) test, urease and lysine iron agar (LIA) test for conventional identification. The biochemically positive colonies were further confirmed by PCR using genus-specific primer invA . Serotyping was done at National Salmonella and Escherichia Centre, Central Research Institute, Kasauli, India.
Lambda red recombinase method  was used to generate the auxotrophic mutant of Salmonella Oslo by inducing deletions in argH and leuB genes, which code for arginine and leucine respectively. Biofilm assay was performed using the method described by Stepanovic et al (2004) .
To compare the growth kinetics of Salmonella Oslo (SO1-wild type) and its mutant (LAT9), a 100 µl aliquot of overnight culture of SO1 and LAT9 was added to 5 ml Luria Bertani broth (HiMedia Laboratory Pvt Ltd, India) and incubated at 37°C with shaking at 200 rpm. The optical density was measured at 600 nm (OD600) at different time points such as 0, 1, 2 to 24 h after incubation and expressed as log (OD600 X 1000).
To sequence the genome of SO1 and its laboratory generated mutant, bacterial genomic DNA was extracted using a QIAamp DNA mini kit (Qiagen, Germany). The quality of the extracted DNA was checked by Qubit® and further verified by a bioanalyzer (Agilent technologies). The genomic DNA library was prepared using a Nextera XT DNA library preparation kit (Illumina, Inc, Cambridge, UK). The whole genome sequencing was performed at UCD, Dublin. The raw sequence data were generated using the Illumina MiSeq platform with a depth of 100x. The obtained paired end reads were merged and the genome was assembled using CLC genomics (version 11) . The processed reads were aligned to the reference genome LT2 strain (LT571437) with Bowtie2 program. The annotation and gene prediction of draft genome was done using the Rapid Annotations Subsystems Technology (RAST) (http://rast.nmpdr.org/) .
The identification of the isolate as true Salmonella enterica serovar Oslo was confirmed by serotyping experiments. As expected, the auxotrophic strain (LAT9) was found to be phenotypically mutant to amino acid arginine and leucine. However, when PCR was performed to confirm the changes in the target genes (argH and leuB), it revealed no deletions in argH and leuB genes. This strange observation prompted us to determine the whole genome sequence of wild (SO1) and mutant (LAT9) strain. The generated library produced a total of 1193762 and 1221694 reads for wild type and mutant respectively. The paired end reads of SO1 were assembled into 121 contigs with coverage of 100x. The genome size was calculated at 4,860,262 bp comprising of 4,974 protein coding genes. The GC content of this strain was found to be 52.2%. The analysis obtained from the RAST also revealed 401 subsystems (Fig. 1). The annotated genome had 383 amino acid biosynthesis genes including argH and leuB. In addition, 78 tRNAs, 11 ncRNAs, 168 pseudo genes were also identified.
Similarly, the paired end reads of LAT9 were assembled into 199 contigs with coverage of 100x. The genome size was calculated at 4,890,414 bp comprising of 5,082 protein coding genes. The GC content of this strain was found to be 52.2%. The analysis obtained from the RAST also revealed 402 subsystems (Fig. 2). The annotated genome had 392 amino acid biosynthesis genes. 79 tRNAs, 11 ncRNAs, 239 pseudo genes were also identified.
Calcoflour stained images of SO1 (A) and LAT9 (B) strains under fluorescent microscope.(Click on the image to enlarge.)
Further, the growth kinetic analysis revealed that the growth of LAT9 was significantly (p-value of >0.001) slower than SO1 (Fig 3). The biofilm forming ability of LAT9 was also significantly reduced when compared with SO1 (Fig 4).
To the best of our knowledge, this is the first draft genome sequence of Salmonella Oslo isolated from seafood and its auxotrophic mutant LAT9. Determination of anti-cancer activity of this laboratory generated auxotrophic mutant using cell line and animal models would provide a suitable alternative to S. Typhimurium VNP20009 as candidate strains for bacteria-mediated anticancer therapy.
The whole genome shotgun projects have been submitted to GenBank and the assigned accession numbers are as follows: NZ_SJXK00000000 for SO1 and NZ_SMLR00000000 for LAT9. The version described in the paper represents the first version.
Financial support received from Nitte (Deemed to be University) and EMBO in collaboration with UCD (Dr. Seamus Fanning's Laboratory, Centre for food safety and zoonoses, Dublin) to the corresponding author is gratefully acknowledged.
The corresponding author has received financial support for this study from DST-SERB, Government of India in the form of an extramural grant (Grant no. ECR/2017/ 000559) and from Nitte (Deemed to be University) in the form of an intramural grant (NUFR1/2016/19-04).
The authors have declared that no competing interest exists.
1. Deekshit VK, Kumar BK, Rai P, Karunasagar I, Karunasagar I. Differential expression of virulence genes and role of gyrA mutations in quinolone resistant and susceptible strains of S almonella W eltevreden and Newport isolated from seafood. J Appl Microbiol. 2015;119(4):970-80 doi: 10.1111/jam.12924
2. Chen G, Tang B, Yang BY, Chen JX, Zhou JH, Li JH, Hua ZC. Tumor-targeting Salmonella typhimurium, a natural tool for activation of prodrug 6MePdR and their combination therapy in murine melanoma model. Appl Microbiol Biotechnol. 2013;97(10):4393-401 doi: 10.1007/s00253-012-4321-8
3. Broadway KM, Suh S, Behkam B, Scharf BE. Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009. J Biotechnol. 2017;251:76-83 doi: 10.1016/j.jbiotec.2017.04.006
4. Coutermarsh-Ott SL, Broadway KM, Scharf BE, Allen IC. Effect of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression. Oncotarget. 2017;8(20):33601. doi: 10.18632/oncotarget.16830
5. Yano S, Zhang Y, Zhao M, Hiroshima Y, Miwa S, Uehara F, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, Hoffman RM. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy. Cell Cycle. 2014;13(24):3958-63 doi: 10.4161/15384101.2014.964115
6. Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Li S, Han Q, Tan Y, Zhao M, Li Y, Nelson SD. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic. Cell Cycle. 2018;17(6):801-9 doi: 10.1080/15384101.2018.1431596
7. Fu W, Lan H, Li S, Han X, Gao T, Ren D. Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors. Cancer Gene Therapy. 2008;15(7):474. doi: 10.1038/cgt.2008.19
8. Jazeela K, Chakraborty A, Karunasagar I, Vijaya Kumar D. Non-Typhoidal Salmonella: A Potential Anti-Cancer Agent. J Appl Microbiol. 2019 https://doi.org/10.1111/jam.14297
9. Pangilinan CR, Lee CH. Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy. Biomedicines. 2019;7(2):36. doi: 10.3390/biomedicines7020036
10. Zhou S, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018:1 doi: 10.1038/s41568-018-0070-z
11. Andrews WH, Hammack T. Salmonella. In Bacteriological Analytical Manual US Food and Drug Administration. Available from: http://www.fda.gov/Food/ScienceResearch/LaboratoryMethods/BacteriologicalAnalytical ManualBAM/default.htm. 2011
12. Deekshit VK, Kumar BK, Rai P, Srikumar S, Karunasagar I, Karunasagar I. Detection of class 1 integrons in Salmonella Weltevreden and silent antibiotic resistance genes in some seafood-associated nontyphoidal isolates of Salmonella in south-west coast of India. J Appl Microbiol. 2012;112(6):1113-22 doi: 10.1111/j.1365-2672.2012.05290.x
13. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proceedings of the National Academy of Sciences. 2000;97(12):6640-5 DOI: 10.1073/pnas.120163297
14. Stepanović S, Ćirković I, Ranin L, S vabić-Vlahović M. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface. Lett Appl Microbiol. 2004;38(5):428-32 DOI: 10.1111/j.1472-765X.2004. 01513.x
15. Founoua LL, Founoua RC, Allamd M, Ismail A, Essack SY. Draft genome sequence of a methicillin-resistant Staphylococcus epidermidis isolate from swine. J Glob Antimicrob Resist. 2018;15:250-251 DOI: 10.1016/j.jgar.2018.10.016
16. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T. et al. The RAST Server: rapid annotations using subsystems technology. BMC genomics. 2008;9(1):75. https://doi.org/10.1186/1471-2164-9-75
Corresponding author: Vijaya Kumar Deekshit, Ph.D. Assistant Professor; Nitte University Center for Science Education and Research (NUCSER), Kotekar Beeri Road, Paneer campus, Deralakatte, Nitte (Deemed to be University), Mangalore-575018, India, Phone no: +91 9880849437, Fax no: +91-8242204300/301/302, E-mail: deekshit1486edu.in.